Kevin G. Barker - Attorney Profiles - BBS&G Attorneys
Bregman, Berbert, Schwartz & Gilday, LLC
Attorneys
Kevin  G. Barker

PRACTICES

Business, Commercial, Employment Law
Litigation and Alternative Dispute Resolution

EDUCATION

J.D. 2010; Cum Laude
American University, Washington College of Law
Washington, D.C.
Editor in Chief, Administrative Law Review

B.A. 2007; Magna Cum Laude 
University of Georgia
Athens, GA

ADMISSIONS

  • New York, 2011
  • Maryland, 2012
  • District of Columbia, 2012

Clerkship

  • United States District Court, Western District of Louisiana, 2010-2011
Kevin G. Barker
Associate
CONTACT INFORMATION
Tel: 301-656-2707
Fax: 301-961-6525
V-Card
Kevin Barker’s practice focuses on complex civil litigation and real estate transactional work. He represents clients on litigation and transactional matters related to the following areas: the acquisition, disposition, development, construction, leasing, and management of real estate assets, including commercial office buildings, shopping centers, mixed-use developments, and hotels and restaurants; land use, zoning, and permitting; contract disputes and general torts, including fraud, business interference, and professional malpractice; and landlord and tenant law.
 
Mr. Barker also has experience with public and private internal investigations, acting both as independent counsel in conducting investigations and as private counsel to businesses and individuals involved in investigatory probes. Additionally, he has experience in corporate governance matters, including mergers and acquisitions, finance, business management and restructuring, and Employee Stock Ownership Plans (ESOPs).
 
Prior to joining Bregman, Berbert, Schwartz & Gilday, Mr. Barker served as a law clerk to the Honorable Robert G. James, who was then the Chief Judge of the United States District Court for the Western District of Louisiana.
 
Mr. Barker is licensed to practice law in Maryland, the District of Columbia, and New York.
 

Publications & Seminars

  • Comment, Thank You for Regulating: Why Philip Morris's Embrace of FDA Regulation Helps the Company but Harms the Agency, 61 ADMIN. L. REV. 197 (2009).